Low-density lipoprotein oxidation and atherogenesis: We got the bandwagon, we got the band, but where's the music?

被引：2
|
作者：
Eaton, JW
机构：
来源：
REDOX REPORT | 1996年 / 2卷 / 02期
关键词：
D O I：
10.1080/13510002.1996.11747031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：81 / 82
页数：2
相关论文
共 38 条
  • [31] Can We Eliminate Low-Density Lipoprotein Cholesterol-Related Cardiovascular Events Through More Aggressive Primary Prevention Therapy?
    Mancini, G. B. John
    Hegele, Robert A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (05) : 546 - 551
  • [32] Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice
    Napoli, C
    Ackah, E
    de Nigris, F
    Del Soldato, P
    D'Armiento, FP
    Crimi, E
    Condorelli, M
    Sessa, WC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12467 - 12470
  • [33] Statin use and low-density lipoprotein cholesterol goals in 2004: How are we doing applying national cholesterol education program III guidelines?
    Steinberg, BA
    O'Hagan, P
    Chadwell, P
    Turner, G
    Cannon, CP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 209A - 209A
  • [34] Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H2S)
    Jeney, Viktoria
    Komodi, Edina
    Nagy, Emoke
    Zarjou, Abolfazl
    Vercellotti, Gregory M.
    Eaton, John W.
    Balla, Gyorgy
    Balla, Jozsef
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (05) : 616 - 623
  • [35] Do We Expect Any Pleiotropic Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition for Reducing Cardiovascular Events Beyond Low-Density Lipoprotein Cholesterol Reduction?
    Tada, Hayato
    Kawashiri, Masa-aki
    Yamagishi, Masakazu
    CIRCULATION JOURNAL, 2017, 81 (08) : 1098 - 1099
  • [36] Low-density lipoprotein cholesterol (LDL-C) levels in pediatric patients with type 1 diabetes mellitus (T1DM): Do we need to be concerned?
    Broussard, Julia R.
    Vanmorlan, Amie
    Dileepan, Kavitha
    Midyett, Kurt
    Ugrasbul, Figen
    DIABETES, 2007, 56 : A481 - A481
  • [37] Potential Health Implication of in Vitro Human Low-Density Lipoprotein-Vitamin E Oxidation Modulation by Polyphenols Derived from Cote d'Ivoire's Oil Palm Species
    Monde, Absalome
    Carbonneau, Marie-Annette
    Michel, Francoise
    Lauret, Celine
    Diabate, Sekou
    Konan, Eugene
    Sess, Daniel
    Cristol, Jean-Paul
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (17) : 9166 - 9171
  • [38] The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet's disease
    Örem, A
    Yandi, YE
    Vanizor, B
    Çimsit, G
    Uydu, HA
    Malkoç, M
    CLINICAL BIOCHEMISTRY, 2002, 35 (03) : 217 - 224
1234